Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02685267
Title Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (Doce/Enza)
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Prostate Cancer Clinical Trials Consortium

prostate adenocarcinoma


Docetaxel + Enzalutamide + Prednisone

Docetaxel + Prednisone

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.